Symposium "Fixed-dose combination pills for cardiovascul ar disease and hypertension: Perspectives and lessons le arned from HIV/AIDS & TB’ July 3rd London School of Hygiene and Tropical Medicine:

1 July, 2018

Dera HIFA colleagues,

Please find below an invitation to HIFA members to participate in a conference this Tuesday 3 July at the London School of Hygiene and Tropical Medicine. The event will also be livestreamed. If you are planning to go to this and are willing to publicise HIFA at the event, please let me know: neil@hifa.org

--

Dear Neil,

With apologies for the short notice, I’m getting in touch about a symposium being hosted in London on 3rd July by the London School of Hygiene and Tropical Medicine with The George Institute for Global Health and Medécins sans Frontières, entitled ‘Fixed-dose combination pills for cardiovascular disease and hypertension: Perspectives and lessons learned from HIV/AIDS & TB’ (programme attached). Diana Gibb from UCL suggested I contact you. We thought this event would be of particular interest to the HIFA network as we are trying to drive the agenda forward on accessibility, availability and affordability of medications for NCDs, particularly hypertension and CVD.

The event will bring together experts working on FDCs for CVD and hypertension together with those working in the fields of HIV and TB, to discuss the barriers to uptake and use of FDCs for prevention of CVD, including FDC for secondary prevention and hypertension. These have shown promising results, but progress on their uptake and use has been slow; notably, applications to include these FDCs for secondary prevention and hypertension in WHO’s Essential Medicines List have not been successful. The aim of the symposium is to provoke a lively discussion around the barriers to FDC implementation and explore the next steps in moving this agenda forward.

It would be fantastic if someone from HIFA were available to attend on the day as the civil society/advocacy perspective is so important. The event will also be livestreamed. I'd be grateful, also, if you could circulate through your networks (information below).

Many thanks,

Éimhín

Dr Éimhín Ansbro,

MBBCh MSc MICGP

Research Fellow in Non-communicable Diseases in Humanitarian Settings

Department of Non-communicable Disease Epidemiology

Faculty of Epidemiology and Population Health

London School of Hygiene & Tropical Medicine

Keppel Street, London WC1E 7HT, UK

Email: eimhin.ansbro@lshtm.ac.uk

Please join us at the

London School of Hygiene and Tropical Medicine

July 3rd 2018, 9am - 5pm

for a Symposium on:

Fixed-dose combinations for cardiovascular disease and hypertension:

Perspectives and lessons learned from HIV/AIDS and TB

The Global Centre for Chronic Conditions at LSHTM, the George Institute for Global Health, Sydney and Médecins sans Frontières will co-host this symposium.

Fixed-dose combinations (FDC) for prevention of atherosclerotic cardiovascular disease (CVD), including FDCs for secondary prevention and hypertension, have shown promising results but progress on their uptake and use has been slow. Notably, applications to include these FDCs for secondary prevention and hypertension in the World Health Organization (WHO) Essential Medicine List (EML) have not been successful.

This international symposium will bring experts working on FDCs for CVD and hypertension together with experts working in the fields of HIV and TB, as well as representatives from governmental, non-governmental organizations, industry and funders. The final aim is to provoke a lively discussion around the barriers to FDC implementation, particularly in relation to the EML and to explore the next steps in moving this agenda forward through further research, advocacy and policy change.

Professor Baron Peter Piot, Director of the London School of Hygiene & Tropical Medicine, will give the welcome address and speakers will include Dr Helen Bygrave, MSF Access Campaign, Dr Ruth Webster, The George Institute for Global Health, Dr Stephen MacMahon, Professor of Global Health, University of Oxford, and Dr Giorgio Roscigno, Global Alliance for TB Drug Development and representatives from the World Health Organization, among others.

Link to register:

https://www.lshtm.ac.uk/newsevents/events/fixed-dose-combination-pills-n...

--

Best wishes, Neil

Let's build a future where people are no longer dying for lack of healthcare information - Join HIFA: www.hifa.org

HIFA profile: Neil Pakenham-Walsh is coordinator of the HIFA global health campaign (Healthcare Information For All - www.hifa.org ), a global community with more than 18,000 members in 177 countries, interacting on five global forums in three languages. He also currently chairs the Dgroups Foundation (www.dgroups.info), which supports 800 communities of practice on international development, health and social justice. Twitter: @hifa_org FB: facebook.com/HIFAdotORG neil@hifa.org